This website uses cookies for usage measurement and traffic analysis purposes.
By clicking the "Agree" button or continuing to browse this site, you consent to the use of cookies.
For more details, please refer to the Privacy Policy (opens in a new window).
Department | Department of Pediatric Oncology |
---|
I have been providing cancer treatment for children and AYAs at the National Cancer Center Hospital. The development of new drugs for pediatric oncology has been slow due to the fact that pediatric oncology is a rare cancer and drug metabolism is different from that of adults. Currently, I am involved in the development of new drugs so that more children can receive them. I am also interested in conducting research in cooperation with overseas countries to eliminate drug lag.
New drug development for pediatric oncology, international collaborative research in the pediatric field
2022-present | National Cancer Center Hospital, Clinical Research Support Office/Department of Pediactric Oncology, |
2017~2022 | National Cancer Center Hospital, Department of Pediactric Oncology |
Board Certified Pediatrician
Diplomate, Subspecialty Board of Medical Oncology
General Clinical Oncologist